Flagship Pioneering’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $120M | Hold |
|
|||||
|
2025
Q2 | $128M | Hold |
|
|||||
|
2025
Q1 | $131M | Hold |
|
|||||
|
2024
Q4 | $193M | Hold |
|
|||||
|
2024
Q3 | $310M | Hold |
|
|||||
|
2024
Q2 | $550M | Sell |
|
|||||
|
2024
Q1 | $1.03B | Hold |
|
|||||
|
2023
Q4 | $961M | Hold |
|
|||||
|
2023
Q3 | $998M | Sell |
|
|||||
|
2023
Q2 | $1.57B | Hold |
|
|||||
|
2023
Q1 | $1.98B | Hold |
|
|||||
|
2022
Q4 | $2.31B | Hold |
|
|||||
|
2022
Q3 | $1.52B | Hold |
|
|||||
|
2022
Q2 | $1.84B | Sell |
|
|||||
|
2022
Q1 | $3.03B | Hold |
|
|||||
|
2021
Q4 | $4.47B | Hold |
|
|||||
|
2021
Q3 | $6.77B | Sell |
|
|||||
|
2021
Q2 | $4.84B | Hold |
|
|||||
|
2021
Q1 | $2.7B | Sell |
|
|||||
|
2020
Q4 | $3.23B | Hold |
|
|||||
|
2020
Q3 | $2.18B | Sell |
|
|||||
|
2020
Q2 | $2.56B | Sell |
|
|||||
|
2020
Q1 | $1.52B | Hold |
|
|||||
|
2019
Q4 | $995M | Sell |
|
|||||
|
2019
Q3 | $936M | Hold |
|
|||||
|
2019
Q2 | $861M | Hold |
|
|||||
|
2019
Q1 | $1.2B | Hold |
|
|||||
|
2018
Q4 | $898M | Buy |
|